Clinical Trial Update: Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed safety and efficacy of the mFOLFOX-6 regimen with cetuximab in metastatic colorectal cancer with wild-type KRAS, including maintenan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• mFOLFOX-6

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED